Global Vaginal Anti Infectives Market Research Report 2024(Status and Outlook)
Report Overview:
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. 'Yeast' infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
The Global Vaginal Anti Infectives Market Size was estimated at USD 3220.73 million in 2023 and is projected to reach USD 4365.65 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Vaginal Anti Infectives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaginal Anti Infectives Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaginal Anti Infectives market in any manner.
Global Vaginal Anti Infectives Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Market Segmentation (by Type)
Oral
Ointment
Market Segmentation (by Application)
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaginal Anti Infectives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Vaginal anti-infectives are the type of agents that are used for the killing or supressing the infection of vagina caused by numerous bacteria, virus, fungi or micro-organism. These bacteria and others invade the host by means of its replication or releasing several toxins into the host. 'Yeast' infections, tyrichomoniasis vaginitis, bacterial vaginosis, chlamydia vaginitis, and viral vaginitis are the major forms of vaginitis. About one third women all over the world experience indications of vaginitis at some point in their lifetime. Women are highly prone to vaginitis during the reproductive age; a change in the balance of bacteria and yeast present in vagina can lead to vaginitis.
The Global Vaginal Anti Infectives Market Size was estimated at USD 3220.73 million in 2023 and is projected to reach USD 4365.65 million by 2029, exhibiting a CAGR of 5.20% during the forecast period.
This report provides a deep insight into the global Vaginal Anti Infectives market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaginal Anti Infectives Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaginal Anti Infectives market in any manner.
Global Vaginal Anti Infectives Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer Inc
Mylan N.V
Novartis AG
Hikma Pharmaceuticals plc
Aurobindo Pharma
AbbVie Inc
Melinta Therapeutics, Inc
Bristol-Myers Squibb Company
GSK plc
Bayer AG
Lupin
Perrigo Company plc
Bayer
Sanofi
Scynexis
Bausch Health Companies Inc
Market Segmentation (by Type)
Oral
Ointment
Market Segmentation (by Application)
Bacterial Vaginitis
Trichomonal Vaginitis
Candida Vaginitis
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Vaginal Anti Infectives Market
- Overview of the regional outlook of the Vaginal Anti Infectives Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaginal Anti Infectives Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaginal Anti Infectives
1.2 Key Market Segments
1.2.1 Vaginal Anti Infectives Segment by Type
1.2.2 Vaginal Anti Infectives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VAGINAL ANTI INFECTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaginal Anti Infectives Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaginal Anti Infectives Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VAGINAL ANTI INFECTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaginal Anti Infectives Sales by Manufacturers (2019-2024)
3.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaginal Anti Infectives Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaginal Anti Infectives Sales Sites, Area Served, Product Type
3.6 Vaginal Anti Infectives Market Competitive Situation and Trends
3.6.1 Vaginal Anti Infectives Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VAGINAL ANTI INFECTIVES INDUSTRY CHAIN ANALYSIS
4.1 Vaginal Anti Infectives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VAGINAL ANTI INFECTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaginal Anti Infectives Sales Market Share by Type (2019-2024)
6.3 Global Vaginal Anti Infectives Market Size Market Share by Type (2019-2024)
6.4 Global Vaginal Anti Infectives Price by Type (2019-2024)
7 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaginal Anti Infectives Market Sales by Application (2019-2024)
7.3 Global Vaginal Anti Infectives Market Size (M USD) by Application (2019-2024)
7.4 Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
8 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY REGION
8.1 Global Vaginal Anti Infectives Sales by Region
8.1.1 Global Vaginal Anti Infectives Sales by Region
8.1.2 Global Vaginal Anti Infectives Sales Market Share by Region
8.2 North America
8.2.1 North America Vaginal Anti Infectives Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaginal Anti Infectives Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaginal Anti Infectives Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaginal Anti Infectives Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaginal Anti Infectives Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Vaginal Anti Infectives Basic Information
9.1.2 Pfizer Inc Vaginal Anti Infectives Product Overview
9.1.3 Pfizer Inc Vaginal Anti Infectives Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Vaginal Anti Infectives SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Mylan N.V
9.2.1 Mylan N.V Vaginal Anti Infectives Basic Information
9.2.2 Mylan N.V Vaginal Anti Infectives Product Overview
9.2.3 Mylan N.V Vaginal Anti Infectives Product Market Performance
9.2.4 Mylan N.V Business Overview
9.2.5 Mylan N.V Vaginal Anti Infectives SWOT Analysis
9.2.6 Mylan N.V Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Vaginal Anti Infectives Basic Information
9.3.2 Novartis AG Vaginal Anti Infectives Product Overview
9.3.3 Novartis AG Vaginal Anti Infectives Product Market Performance
9.3.4 Novartis AG Vaginal Anti Infectives SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Hikma Pharmaceuticals plc
9.4.1 Hikma Pharmaceuticals plc Vaginal Anti Infectives Basic Information
9.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
9.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Market Performance
9.4.4 Hikma Pharmaceuticals plc Business Overview
9.4.5 Hikma Pharmaceuticals plc Recent Developments
9.5 Aurobindo Pharma
9.5.1 Aurobindo Pharma Vaginal Anti Infectives Basic Information
9.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Overview
9.5.3 Aurobindo Pharma Vaginal Anti Infectives Product Market Performance
9.5.4 Aurobindo Pharma Business Overview
9.5.5 Aurobindo Pharma Recent Developments
9.6 AbbVie Inc
9.6.1 AbbVie Inc Vaginal Anti Infectives Basic Information
9.6.2 AbbVie Inc Vaginal Anti Infectives Product Overview
9.6.3 AbbVie Inc Vaginal Anti Infectives Product Market Performance
9.6.4 AbbVie Inc Business Overview
9.6.5 AbbVie Inc Recent Developments
9.7 Melinta Therapeutics, Inc
9.7.1 Melinta Therapeutics, Inc Vaginal Anti Infectives Basic Information
9.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
9.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Market Performance
9.7.4 Melinta Therapeutics, Inc Business Overview
9.7.5 Melinta Therapeutics, Inc Recent Developments
9.8 Bristol-Myers Squibb Company
9.8.1 Bristol-Myers Squibb Company Vaginal Anti Infectives Basic Information
9.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
9.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Market Performance
9.8.4 Bristol-Myers Squibb Company Business Overview
9.8.5 Bristol-Myers Squibb Company Recent Developments
9.9 GSK plc
9.9.1 GSK plc Vaginal Anti Infectives Basic Information
9.9.2 GSK plc Vaginal Anti Infectives Product Overview
9.9.3 GSK plc Vaginal Anti Infectives Product Market Performance
9.9.4 GSK plc Business Overview
9.9.5 GSK plc Recent Developments
9.10 Bayer AG
9.10.1 Bayer AG Vaginal Anti Infectives Basic Information
9.10.2 Bayer AG Vaginal Anti Infectives Product Overview
9.10.3 Bayer AG Vaginal Anti Infectives Product Market Performance
9.10.4 Bayer AG Business Overview
9.10.5 Bayer AG Recent Developments
9.11 Lupin
9.11.1 Lupin Vaginal Anti Infectives Basic Information
9.11.2 Lupin Vaginal Anti Infectives Product Overview
9.11.3 Lupin Vaginal Anti Infectives Product Market Performance
9.11.4 Lupin Business Overview
9.11.5 Lupin Recent Developments
9.12 Perrigo Company plc
9.12.1 Perrigo Company plc Vaginal Anti Infectives Basic Information
9.12.2 Perrigo Company plc Vaginal Anti Infectives Product Overview
9.12.3 Perrigo Company plc Vaginal Anti Infectives Product Market Performance
9.12.4 Perrigo Company plc Business Overview
9.12.5 Perrigo Company plc Recent Developments
9.13 Bayer
9.13.1 Bayer Vaginal Anti Infectives Basic Information
9.13.2 Bayer Vaginal Anti Infectives Product Overview
9.13.3 Bayer Vaginal Anti Infectives Product Market Performance
9.13.4 Bayer Business Overview
9.13.5 Bayer Recent Developments
9.14 Sanofi
9.14.1 Sanofi Vaginal Anti Infectives Basic Information
9.14.2 Sanofi Vaginal Anti Infectives Product Overview
9.14.3 Sanofi Vaginal Anti Infectives Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Scynexis
9.15.1 Scynexis Vaginal Anti Infectives Basic Information
9.15.2 Scynexis Vaginal Anti Infectives Product Overview
9.15.3 Scynexis Vaginal Anti Infectives Product Market Performance
9.15.4 Scynexis Business Overview
9.15.5 Scynexis Recent Developments
9.16 Bausch Health Companies Inc
9.16.1 Bausch Health Companies Inc Vaginal Anti Infectives Basic Information
9.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
9.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Product Market Performance
9.16.4 Bausch Health Companies Inc Business Overview
9.16.5 Bausch Health Companies Inc Recent Developments
10 VAGINAL ANTI INFECTIVES MARKET FORECAST BY REGION
10.1 Global Vaginal Anti Infectives Market Size Forecast
10.2 Global Vaginal Anti Infectives Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaginal Anti Infectives Market Size Forecast by Country
10.2.3 Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region
10.2.4 South America Vaginal Anti Infectives Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaginal Anti Infectives by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Vaginal Anti Infectives Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaginal Anti Infectives by Type (2025-2030)
11.1.2 Global Vaginal Anti Infectives Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaginal Anti Infectives by Type (2025-2030)
11.2 Global Vaginal Anti Infectives Market Forecast by Application (2025-2030)
11.2.1 Global Vaginal Anti Infectives Sales (Kilotons) Forecast by Application
11.2.2 Global Vaginal Anti Infectives Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaginal Anti Infectives
1.2 Key Market Segments
1.2.1 Vaginal Anti Infectives Segment by Type
1.2.2 Vaginal Anti Infectives Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VAGINAL ANTI INFECTIVES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaginal Anti Infectives Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Vaginal Anti Infectives Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VAGINAL ANTI INFECTIVES MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaginal Anti Infectives Sales by Manufacturers (2019-2024)
3.2 Global Vaginal Anti Infectives Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaginal Anti Infectives Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaginal Anti Infectives Sales Sites, Area Served, Product Type
3.6 Vaginal Anti Infectives Market Competitive Situation and Trends
3.6.1 Vaginal Anti Infectives Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaginal Anti Infectives Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VAGINAL ANTI INFECTIVES INDUSTRY CHAIN ANALYSIS
4.1 Vaginal Anti Infectives Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VAGINAL ANTI INFECTIVES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaginal Anti Infectives Sales Market Share by Type (2019-2024)
6.3 Global Vaginal Anti Infectives Market Size Market Share by Type (2019-2024)
6.4 Global Vaginal Anti Infectives Price by Type (2019-2024)
7 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaginal Anti Infectives Market Sales by Application (2019-2024)
7.3 Global Vaginal Anti Infectives Market Size (M USD) by Application (2019-2024)
7.4 Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
8 VAGINAL ANTI INFECTIVES MARKET SEGMENTATION BY REGION
8.1 Global Vaginal Anti Infectives Sales by Region
8.1.1 Global Vaginal Anti Infectives Sales by Region
8.1.2 Global Vaginal Anti Infectives Sales Market Share by Region
8.2 North America
8.2.1 North America Vaginal Anti Infectives Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Vaginal Anti Infectives Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Vaginal Anti Infectives Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Vaginal Anti Infectives Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Vaginal Anti Infectives Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer Inc
9.1.1 Pfizer Inc Vaginal Anti Infectives Basic Information
9.1.2 Pfizer Inc Vaginal Anti Infectives Product Overview
9.1.3 Pfizer Inc Vaginal Anti Infectives Product Market Performance
9.1.4 Pfizer Inc Business Overview
9.1.5 Pfizer Inc Vaginal Anti Infectives SWOT Analysis
9.1.6 Pfizer Inc Recent Developments
9.2 Mylan N.V
9.2.1 Mylan N.V Vaginal Anti Infectives Basic Information
9.2.2 Mylan N.V Vaginal Anti Infectives Product Overview
9.2.3 Mylan N.V Vaginal Anti Infectives Product Market Performance
9.2.4 Mylan N.V Business Overview
9.2.5 Mylan N.V Vaginal Anti Infectives SWOT Analysis
9.2.6 Mylan N.V Recent Developments
9.3 Novartis AG
9.3.1 Novartis AG Vaginal Anti Infectives Basic Information
9.3.2 Novartis AG Vaginal Anti Infectives Product Overview
9.3.3 Novartis AG Vaginal Anti Infectives Product Market Performance
9.3.4 Novartis AG Vaginal Anti Infectives SWOT Analysis
9.3.5 Novartis AG Business Overview
9.3.6 Novartis AG Recent Developments
9.4 Hikma Pharmaceuticals plc
9.4.1 Hikma Pharmaceuticals plc Vaginal Anti Infectives Basic Information
9.4.2 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
9.4.3 Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Market Performance
9.4.4 Hikma Pharmaceuticals plc Business Overview
9.4.5 Hikma Pharmaceuticals plc Recent Developments
9.5 Aurobindo Pharma
9.5.1 Aurobindo Pharma Vaginal Anti Infectives Basic Information
9.5.2 Aurobindo Pharma Vaginal Anti Infectives Product Overview
9.5.3 Aurobindo Pharma Vaginal Anti Infectives Product Market Performance
9.5.4 Aurobindo Pharma Business Overview
9.5.5 Aurobindo Pharma Recent Developments
9.6 AbbVie Inc
9.6.1 AbbVie Inc Vaginal Anti Infectives Basic Information
9.6.2 AbbVie Inc Vaginal Anti Infectives Product Overview
9.6.3 AbbVie Inc Vaginal Anti Infectives Product Market Performance
9.6.4 AbbVie Inc Business Overview
9.6.5 AbbVie Inc Recent Developments
9.7 Melinta Therapeutics, Inc
9.7.1 Melinta Therapeutics, Inc Vaginal Anti Infectives Basic Information
9.7.2 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
9.7.3 Melinta Therapeutics, Inc Vaginal Anti Infectives Product Market Performance
9.7.4 Melinta Therapeutics, Inc Business Overview
9.7.5 Melinta Therapeutics, Inc Recent Developments
9.8 Bristol-Myers Squibb Company
9.8.1 Bristol-Myers Squibb Company Vaginal Anti Infectives Basic Information
9.8.2 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
9.8.3 Bristol-Myers Squibb Company Vaginal Anti Infectives Product Market Performance
9.8.4 Bristol-Myers Squibb Company Business Overview
9.8.5 Bristol-Myers Squibb Company Recent Developments
9.9 GSK plc
9.9.1 GSK plc Vaginal Anti Infectives Basic Information
9.9.2 GSK plc Vaginal Anti Infectives Product Overview
9.9.3 GSK plc Vaginal Anti Infectives Product Market Performance
9.9.4 GSK plc Business Overview
9.9.5 GSK plc Recent Developments
9.10 Bayer AG
9.10.1 Bayer AG Vaginal Anti Infectives Basic Information
9.10.2 Bayer AG Vaginal Anti Infectives Product Overview
9.10.3 Bayer AG Vaginal Anti Infectives Product Market Performance
9.10.4 Bayer AG Business Overview
9.10.5 Bayer AG Recent Developments
9.11 Lupin
9.11.1 Lupin Vaginal Anti Infectives Basic Information
9.11.2 Lupin Vaginal Anti Infectives Product Overview
9.11.3 Lupin Vaginal Anti Infectives Product Market Performance
9.11.4 Lupin Business Overview
9.11.5 Lupin Recent Developments
9.12 Perrigo Company plc
9.12.1 Perrigo Company plc Vaginal Anti Infectives Basic Information
9.12.2 Perrigo Company plc Vaginal Anti Infectives Product Overview
9.12.3 Perrigo Company plc Vaginal Anti Infectives Product Market Performance
9.12.4 Perrigo Company plc Business Overview
9.12.5 Perrigo Company plc Recent Developments
9.13 Bayer
9.13.1 Bayer Vaginal Anti Infectives Basic Information
9.13.2 Bayer Vaginal Anti Infectives Product Overview
9.13.3 Bayer Vaginal Anti Infectives Product Market Performance
9.13.4 Bayer Business Overview
9.13.5 Bayer Recent Developments
9.14 Sanofi
9.14.1 Sanofi Vaginal Anti Infectives Basic Information
9.14.2 Sanofi Vaginal Anti Infectives Product Overview
9.14.3 Sanofi Vaginal Anti Infectives Product Market Performance
9.14.4 Sanofi Business Overview
9.14.5 Sanofi Recent Developments
9.15 Scynexis
9.15.1 Scynexis Vaginal Anti Infectives Basic Information
9.15.2 Scynexis Vaginal Anti Infectives Product Overview
9.15.3 Scynexis Vaginal Anti Infectives Product Market Performance
9.15.4 Scynexis Business Overview
9.15.5 Scynexis Recent Developments
9.16 Bausch Health Companies Inc
9.16.1 Bausch Health Companies Inc Vaginal Anti Infectives Basic Information
9.16.2 Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
9.16.3 Bausch Health Companies Inc Vaginal Anti Infectives Product Market Performance
9.16.4 Bausch Health Companies Inc Business Overview
9.16.5 Bausch Health Companies Inc Recent Developments
10 VAGINAL ANTI INFECTIVES MARKET FORECAST BY REGION
10.1 Global Vaginal Anti Infectives Market Size Forecast
10.2 Global Vaginal Anti Infectives Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Vaginal Anti Infectives Market Size Forecast by Country
10.2.3 Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region
10.2.4 South America Vaginal Anti Infectives Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Vaginal Anti Infectives by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Vaginal Anti Infectives Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Vaginal Anti Infectives by Type (2025-2030)
11.1.2 Global Vaginal Anti Infectives Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Vaginal Anti Infectives by Type (2025-2030)
11.2 Global Vaginal Anti Infectives Market Forecast by Application (2025-2030)
11.2.1 Global Vaginal Anti Infectives Sales (Kilotons) Forecast by Application
11.2.2 Global Vaginal Anti Infectives Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaginal Anti Infectives Market Size Comparison by Region (M USD)
Table 5. Global Vaginal Anti Infectives Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaginal Anti Infectives Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
Table 10. Global Market Vaginal Anti Infectives Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaginal Anti Infectives Sales Sites and Area Served
Table 12. Manufacturers Vaginal Anti Infectives Product Type
Table 13. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaginal Anti Infectives
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaginal Anti Infectives Market Challenges
Table 22. Global Vaginal Anti Infectives Sales by Type (Kilotons)
Table 23. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 24. Global Vaginal Anti Infectives Sales (Kilotons) by Type (2019-2024)
Table 25. Global Vaginal Anti Infectives Sales Market Share by Type (2019-2024)
Table 26. Global Vaginal Anti Infectives Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaginal Anti Infectives Market Size Share by Type (2019-2024)
Table 28. Global Vaginal Anti Infectives Price (USD/Ton) by Type (2019-2024)
Table 29. Global Vaginal Anti Infectives Sales (Kilotons) by Application
Table 30. Global Vaginal Anti Infectives Market Size by Application
Table 31. Global Vaginal Anti Infectives Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Vaginal Anti Infectives Sales Market Share by Application (2019-2024)
Table 33. Global Vaginal Anti Infectives Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaginal Anti Infectives Market Share by Application (2019-2024)
Table 35. Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Vaginal Anti Infectives Sales Market Share by Region (2019-2024)
Table 38. North America Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Vaginal Anti Infectives Basic Information
Table 44. Pfizer Inc Vaginal Anti Infectives Product Overview
Table 45. Pfizer Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Vaginal Anti Infectives SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Mylan N.V Vaginal Anti Infectives Basic Information
Table 50. Mylan N.V Vaginal Anti Infectives Product Overview
Table 51. Mylan N.V Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan N.V Business Overview
Table 53. Mylan N.V Vaginal Anti Infectives SWOT Analysis
Table 54. Mylan N.V Recent Developments
Table 55. Novartis AG Vaginal Anti Infectives Basic Information
Table 56. Novartis AG Vaginal Anti Infectives Product Overview
Table 57. Novartis AG Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Vaginal Anti Infectives SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Hikma Pharmaceuticals plc Vaginal Anti Infectives Basic Information
Table 62. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
Table 63. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Hikma Pharmaceuticals plc Business Overview
Table 65. Hikma Pharmaceuticals plc Recent Developments
Table 66. Aurobindo Pharma Vaginal Anti Infectives Basic Information
Table 67. Aurobindo Pharma Vaginal Anti Infectives Product Overview
Table 68. Aurobindo Pharma Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Aurobindo Pharma Business Overview
Table 70. Aurobindo Pharma Recent Developments
Table 71. AbbVie Inc Vaginal Anti Infectives Basic Information
Table 72. AbbVie Inc Vaginal Anti Infectives Product Overview
Table 73. AbbVie Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AbbVie Inc Business Overview
Table 75. AbbVie Inc Recent Developments
Table 76. Melinta Therapeutics, Inc Vaginal Anti Infectives Basic Information
Table 77. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
Table 78. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Melinta Therapeutics, Inc Business Overview
Table 80. Melinta Therapeutics, Inc Recent Developments
Table 81. Bristol-Myers Squibb Company Vaginal Anti Infectives Basic Information
Table 82. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
Table 83. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol-Myers Squibb Company Business Overview
Table 85. Bristol-Myers Squibb Company Recent Developments
Table 86. GSK plc Vaginal Anti Infectives Basic Information
Table 87. GSK plc Vaginal Anti Infectives Product Overview
Table 88. GSK plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GSK plc Business Overview
Table 90. GSK plc Recent Developments
Table 91. Bayer AG Vaginal Anti Infectives Basic Information
Table 92. Bayer AG Vaginal Anti Infectives Product Overview
Table 93. Bayer AG Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Recent Developments
Table 96. Lupin Vaginal Anti Infectives Basic Information
Table 97. Lupin Vaginal Anti Infectives Product Overview
Table 98. Lupin Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Lupin Business Overview
Table 100. Lupin Recent Developments
Table 101. Perrigo Company plc Vaginal Anti Infectives Basic Information
Table 102. Perrigo Company plc Vaginal Anti Infectives Product Overview
Table 103. Perrigo Company plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Perrigo Company plc Business Overview
Table 105. Perrigo Company plc Recent Developments
Table 106. Bayer Vaginal Anti Infectives Basic Information
Table 107. Bayer Vaginal Anti Infectives Product Overview
Table 108. Bayer Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Bayer Business Overview
Table 110. Bayer Recent Developments
Table 111. Sanofi Vaginal Anti Infectives Basic Information
Table 112. Sanofi Vaginal Anti Infectives Product Overview
Table 113. Sanofi Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sanofi Business Overview
Table 115. Sanofi Recent Developments
Table 116. Scynexis Vaginal Anti Infectives Basic Information
Table 117. Scynexis Vaginal Anti Infectives Product Overview
Table 118. Scynexis Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Scynexis Business Overview
Table 120. Scynexis Recent Developments
Table 121. Bausch Health Companies Inc Vaginal Anti Infectives Basic Information
Table 122. Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
Table 123. Bausch Health Companies Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bausch Health Companies Inc Business Overview
Table 125. Bausch Health Companies Inc Recent Developments
Table 126. Global Vaginal Anti Infectives Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Vaginal Anti Infectives Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Vaginal Anti Infectives Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Vaginal Anti Infectives Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Vaginal Anti Infectives Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Vaginal Anti Infectives Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Vaginal Anti Infectives Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Vaginal Anti Infectives Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Vaginal Anti Infectives Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Vaginal Anti Infectives Market Size Comparison by Region (M USD)
Table 5. Global Vaginal Anti Infectives Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Vaginal Anti Infectives Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Vaginal Anti Infectives Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Vaginal Anti Infectives Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaginal Anti Infectives as of 2022)
Table 10. Global Market Vaginal Anti Infectives Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Vaginal Anti Infectives Sales Sites and Area Served
Table 12. Manufacturers Vaginal Anti Infectives Product Type
Table 13. Global Vaginal Anti Infectives Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Vaginal Anti Infectives
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Vaginal Anti Infectives Market Challenges
Table 22. Global Vaginal Anti Infectives Sales by Type (Kilotons)
Table 23. Global Vaginal Anti Infectives Market Size by Type (M USD)
Table 24. Global Vaginal Anti Infectives Sales (Kilotons) by Type (2019-2024)
Table 25. Global Vaginal Anti Infectives Sales Market Share by Type (2019-2024)
Table 26. Global Vaginal Anti Infectives Market Size (M USD) by Type (2019-2024)
Table 27. Global Vaginal Anti Infectives Market Size Share by Type (2019-2024)
Table 28. Global Vaginal Anti Infectives Price (USD/Ton) by Type (2019-2024)
Table 29. Global Vaginal Anti Infectives Sales (Kilotons) by Application
Table 30. Global Vaginal Anti Infectives Market Size by Application
Table 31. Global Vaginal Anti Infectives Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Vaginal Anti Infectives Sales Market Share by Application (2019-2024)
Table 33. Global Vaginal Anti Infectives Sales by Application (2019-2024) & (M USD)
Table 34. Global Vaginal Anti Infectives Market Share by Application (2019-2024)
Table 35. Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
Table 36. Global Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Vaginal Anti Infectives Sales Market Share by Region (2019-2024)
Table 38. North America Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Vaginal Anti Infectives Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Vaginal Anti Infectives Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Inc Vaginal Anti Infectives Basic Information
Table 44. Pfizer Inc Vaginal Anti Infectives Product Overview
Table 45. Pfizer Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Inc Business Overview
Table 47. Pfizer Inc Vaginal Anti Infectives SWOT Analysis
Table 48. Pfizer Inc Recent Developments
Table 49. Mylan N.V Vaginal Anti Infectives Basic Information
Table 50. Mylan N.V Vaginal Anti Infectives Product Overview
Table 51. Mylan N.V Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Mylan N.V Business Overview
Table 53. Mylan N.V Vaginal Anti Infectives SWOT Analysis
Table 54. Mylan N.V Recent Developments
Table 55. Novartis AG Vaginal Anti Infectives Basic Information
Table 56. Novartis AG Vaginal Anti Infectives Product Overview
Table 57. Novartis AG Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Novartis AG Vaginal Anti Infectives SWOT Analysis
Table 59. Novartis AG Business Overview
Table 60. Novartis AG Recent Developments
Table 61. Hikma Pharmaceuticals plc Vaginal Anti Infectives Basic Information
Table 62. Hikma Pharmaceuticals plc Vaginal Anti Infectives Product Overview
Table 63. Hikma Pharmaceuticals plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Hikma Pharmaceuticals plc Business Overview
Table 65. Hikma Pharmaceuticals plc Recent Developments
Table 66. Aurobindo Pharma Vaginal Anti Infectives Basic Information
Table 67. Aurobindo Pharma Vaginal Anti Infectives Product Overview
Table 68. Aurobindo Pharma Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Aurobindo Pharma Business Overview
Table 70. Aurobindo Pharma Recent Developments
Table 71. AbbVie Inc Vaginal Anti Infectives Basic Information
Table 72. AbbVie Inc Vaginal Anti Infectives Product Overview
Table 73. AbbVie Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AbbVie Inc Business Overview
Table 75. AbbVie Inc Recent Developments
Table 76. Melinta Therapeutics, Inc Vaginal Anti Infectives Basic Information
Table 77. Melinta Therapeutics, Inc Vaginal Anti Infectives Product Overview
Table 78. Melinta Therapeutics, Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Melinta Therapeutics, Inc Business Overview
Table 80. Melinta Therapeutics, Inc Recent Developments
Table 81. Bristol-Myers Squibb Company Vaginal Anti Infectives Basic Information
Table 82. Bristol-Myers Squibb Company Vaginal Anti Infectives Product Overview
Table 83. Bristol-Myers Squibb Company Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bristol-Myers Squibb Company Business Overview
Table 85. Bristol-Myers Squibb Company Recent Developments
Table 86. GSK plc Vaginal Anti Infectives Basic Information
Table 87. GSK plc Vaginal Anti Infectives Product Overview
Table 88. GSK plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GSK plc Business Overview
Table 90. GSK plc Recent Developments
Table 91. Bayer AG Vaginal Anti Infectives Basic Information
Table 92. Bayer AG Vaginal Anti Infectives Product Overview
Table 93. Bayer AG Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bayer AG Business Overview
Table 95. Bayer AG Recent Developments
Table 96. Lupin Vaginal Anti Infectives Basic Information
Table 97. Lupin Vaginal Anti Infectives Product Overview
Table 98. Lupin Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Lupin Business Overview
Table 100. Lupin Recent Developments
Table 101. Perrigo Company plc Vaginal Anti Infectives Basic Information
Table 102. Perrigo Company plc Vaginal Anti Infectives Product Overview
Table 103. Perrigo Company plc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Perrigo Company plc Business Overview
Table 105. Perrigo Company plc Recent Developments
Table 106. Bayer Vaginal Anti Infectives Basic Information
Table 107. Bayer Vaginal Anti Infectives Product Overview
Table 108. Bayer Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Bayer Business Overview
Table 110. Bayer Recent Developments
Table 111. Sanofi Vaginal Anti Infectives Basic Information
Table 112. Sanofi Vaginal Anti Infectives Product Overview
Table 113. Sanofi Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sanofi Business Overview
Table 115. Sanofi Recent Developments
Table 116. Scynexis Vaginal Anti Infectives Basic Information
Table 117. Scynexis Vaginal Anti Infectives Product Overview
Table 118. Scynexis Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Scynexis Business Overview
Table 120. Scynexis Recent Developments
Table 121. Bausch Health Companies Inc Vaginal Anti Infectives Basic Information
Table 122. Bausch Health Companies Inc Vaginal Anti Infectives Product Overview
Table 123. Bausch Health Companies Inc Vaginal Anti Infectives Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Bausch Health Companies Inc Business Overview
Table 125. Bausch Health Companies Inc Recent Developments
Table 126. Global Vaginal Anti Infectives Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Vaginal Anti Infectives Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Vaginal Anti Infectives Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Vaginal Anti Infectives Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Vaginal Anti Infectives Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Vaginal Anti Infectives Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Vaginal Anti Infectives Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Vaginal Anti Infectives Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Vaginal Anti Infectives Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Vaginal Anti Infectives Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Vaginal Anti Infectives Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Vaginal Anti Infectives Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaginal Anti Infectives Market Size (M USD), 2019-2030
Figure 5. Global Vaginal Anti Infectives Market Size (M USD) (2019-2030)
Figure 6. Global Vaginal Anti Infectives Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaginal Anti Infectives Market Size by Country (M USD)
Figure 11. Vaginal Anti Infectives Sales Share by Manufacturers in 2023
Figure 12. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2023
Figure 13. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaginal Anti Infectives Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaginal Anti Infectives Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaginal Anti Infectives Market Share by Type
Figure 18. Sales Market Share of Vaginal Anti Infectives by Type (2019-2024)
Figure 19. Sales Market Share of Vaginal Anti Infectives by Type in 2023
Figure 20. Market Size Share of Vaginal Anti Infectives by Type (2019-2024)
Figure 21. Market Size Market Share of Vaginal Anti Infectives by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaginal Anti Infectives Market Share by Application
Figure 24. Global Vaginal Anti Infectives Sales Market Share by Application (2019-2024)
Figure 25. Global Vaginal Anti Infectives Sales Market Share by Application in 2023
Figure 26. Global Vaginal Anti Infectives Market Share by Application (2019-2024)
Figure 27. Global Vaginal Anti Infectives Market Share by Application in 2023
Figure 28. Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaginal Anti Infectives Sales Market Share by Region (2019-2024)
Figure 30. North America Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 32. U.S. Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Vaginal Anti Infectives Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Vaginal Anti Infectives Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 37. Germany Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region in 2023
Figure 44. China Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 50. South America Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 51. Brazil Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Vaginal Anti Infectives Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Vaginal Anti Infectives Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Vaginal Anti Infectives Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Vaginal Anti Infectives Market Share Forecast by Type (2025-2030)
Figure 65. Global Vaginal Anti Infectives Sales Forecast by Application (2025-2030)
Figure 66. Global Vaginal Anti Infectives Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Vaginal Anti Infectives
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Vaginal Anti Infectives Market Size (M USD), 2019-2030
Figure 5. Global Vaginal Anti Infectives Market Size (M USD) (2019-2030)
Figure 6. Global Vaginal Anti Infectives Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Vaginal Anti Infectives Market Size by Country (M USD)
Figure 11. Vaginal Anti Infectives Sales Share by Manufacturers in 2023
Figure 12. Global Vaginal Anti Infectives Revenue Share by Manufacturers in 2023
Figure 13. Vaginal Anti Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Vaginal Anti Infectives Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Vaginal Anti Infectives Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Vaginal Anti Infectives Market Share by Type
Figure 18. Sales Market Share of Vaginal Anti Infectives by Type (2019-2024)
Figure 19. Sales Market Share of Vaginal Anti Infectives by Type in 2023
Figure 20. Market Size Share of Vaginal Anti Infectives by Type (2019-2024)
Figure 21. Market Size Market Share of Vaginal Anti Infectives by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Vaginal Anti Infectives Market Share by Application
Figure 24. Global Vaginal Anti Infectives Sales Market Share by Application (2019-2024)
Figure 25. Global Vaginal Anti Infectives Sales Market Share by Application in 2023
Figure 26. Global Vaginal Anti Infectives Market Share by Application (2019-2024)
Figure 27. Global Vaginal Anti Infectives Market Share by Application in 2023
Figure 28. Global Vaginal Anti Infectives Sales Growth Rate by Application (2019-2024)
Figure 29. Global Vaginal Anti Infectives Sales Market Share by Region (2019-2024)
Figure 30. North America Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 32. U.S. Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Vaginal Anti Infectives Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Vaginal Anti Infectives Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 37. Germany Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Vaginal Anti Infectives Sales Market Share by Region in 2023
Figure 44. China Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 50. South America Vaginal Anti Infectives Sales Market Share by Country in 2023
Figure 51. Brazil Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Vaginal Anti Infectives Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Vaginal Anti Infectives Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Vaginal Anti Infectives Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Vaginal Anti Infectives Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Vaginal Anti Infectives Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Vaginal Anti Infectives Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Vaginal Anti Infectives Market Share Forecast by Type (2025-2030)
Figure 65. Global Vaginal Anti Infectives Sales Forecast by Application (2025-2030)
Figure 66. Global Vaginal Anti Infectives Market Share Forecast by Application (2025-2030)
